Buyer Name: SOMERSET NHS FOUNDATION TRUST
Buyer Address: Musgrove Park Hospital, Taunton, UKK23, TA15DA, United Kingdom
Contact Name: Hollie Caddy
Contact Email: servicesteam.procurement@SomersetFT.nhs.uk
Buyer Name: SOMERSET NHS FOUNDATION TRUST
Buyer Address: Musgrove Park Hospital, Taunton, UKK23, TA15DA, United Kingdom
Contact Name: Hollie Caddy
Contact Email: servicesteam.procurement@SomersetFT.nhs.uk
Provision of a full end to end testing service, including sampling kit supply, sample transport, and result reporting.
No linked documents found for this notice.
Lot Description: Provision of a full end to end testing service, including sampling kit supply, sample transport, and result reporting. The WID®-easy test is a new, minimally invasive test available in the UK that uses a simple vaginal swab to help detect or rule out the risk of endometrial (womb) cancer in women experiencing abnormal bleeding. It is a far less intrusive procedure, providing faster links to the appropriate clinical pathway. A service evaluation project would aim to test the initial adoption of the WID®-easy test at the Somerset NHS Foundation Trust. The WID®-easy test will be the frontline triage methodology for all women referred to the Trust 45 years or older with AUB and determine the next step in the clinical workflow. This notice is an intention to award a contract under the most suitable provider process. The approximate lifetime value of the contract is £435,000.00. This is a new service with a new provider. The dates between which the services are intended to be provided are between March 2026 and March 2027.
Lot 1 Status: cancelled
Lot 1 Has Options: Yes
Lot 1 Options: 1 x 12 month extension
Lot 1 Award Criterion (cost): most suitable provider process
Contract Title: WID-Easy Somerset Pilot
Award Title: WID-Easy Somerset Pilot
{
"awards": [
{
"id": "013443-2026-1",
"relatedLots": [
"1"
],
"status": "active",
"suppliers": [
{
"id": "GB-COH-07181386",
"name": "Advanced Global Health Limited"
}
],
"title": "WID-Easy Somerset Pilot"
}
],
"bids": {
"statistics": [
{
"id": "1",
"measure": "bids",
"relatedLot": "1",
"value": 1
}
]
},
"buyer": {
"id": "GB-NHS-RH5",
"name": "SOMERSET NHS FOUNDATION TRUST"
},
"contracts": [
{
"awardID": "013443-2026-1",
"dateSigned": "2026-02-13T00:00:00Z",
"id": "013443-2026-1",
"status": "active",
"title": "WID-Easy Somerset Pilot",
"value": {
"amount": 435000.0,
"currency": "GBP"
}
}
],
"date": "2026-02-13T13:52:05Z",
"description": "This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award. The standstill period begins on the day after the publication of this notice. Representations by providers must be made to the relevant authority by 25 February 2026. This contract has not yet formally been awarded; this notice serves as an intention to award under the PSR.\u0027\nRepresentations should be sent: servicesteam.procurement@SomersetFT.nhs.uk\nAward decision-makers; Cancer Programme Manager.\nNo conflicts or potential conflicts of interest of individuals making the decision were identified.\nThe key criteria were weighted as follows:\n30 %\tQuality and Innovation\n20 %\tValue\n20 %\tIntegration, Collaboration and Service Sustainability\n20 %\tImproving access, reducing health inequalities and facilitating choice\n10 %\tSocial value\nQuality and Innovation were weighted highest, with particular emphasis on the potential for earlier diagnosis and improved patient experience being key. Considerable emphasis was also placed on Integration with existing gynaecology and cancer pathways, alongside overall Value, recognising their importance in delivering a coherent, efficient, and sustainable service model.\nThe rationale for choosing the provider with reference to the key criteria:\nThey are uniquely capable of safely delivering the required WID\u2011easy/WID\u2011qEC triage testing at scale, and best meet the PSR key criteria of quality, value, integration and social value. Their clinically validated pathway for peri\u2011 and post\u2011menopausal women with abnormal uterine bleeding is already in operation, with UK evidence showing substantial reductions in unnecessary hysteroscopies while maintaining cancer detection, thereby improving patient experience and safety and supporting earlier diagnosis ambitions. The provider holds the necessary accredited laboratory infrastructure, high\u2011throughput capacity and data\u2011governance arrangements to deliver rapid turnaround times, integrate results into existing gynaecology and cancer pathways, and collaborate with local NHS partners on training, audit and service development, ensuring a proportionate, efficient and sustainable solution that represents best value for the public. They are currently the only provider of this service in the UK.",
"id": "013443-2026",
"initiationType": "tender",
"language": "en",
"ocid": "ocds-h6vhtk-0653fa",
"parties": [
{
"address": {
"countryName": "United Kingdom",
"locality": "Taunton",
"postalCode": "TA15DA",
"region": "UKK23",
"streetAddress": "Musgrove Park Hospital"
},
"contactPoint": {
"email": "servicesteam.procurement@SomersetFT.nhs.uk",
"name": "Hollie Caddy"
},
"details": {
"classifications": [
{
"description": "Body governed by public law",
"id": "BODY_PUBLIC",
"scheme": "TED_CA_TYPE"
},
{
"description": "Health",
"id": "07",
"scheme": "COFOG"
}
],
"url": "https://www.somersetft.nhs.uk/"
},
"id": "GB-NHS-RH5",
"identifier": {
"id": "RH5",
"legalName": "SOMERSET NHS FOUNDATION TRUST",
"scheme": "GB-NHS"
},
"name": "SOMERSET NHS FOUNDATION TRUST",
"roles": [
"buyer"
]
},
{
"address": {
"countryName": "United Kingdom",
"locality": "London",
"postalCode": "SE1 0HS",
"region": "UKI",
"streetAddress": "30 Gt. Guildford Street"
},
"details": {
"scale": "large"
},
"id": "GB-COH-07181386",
"identifier": {
"id": "07181386",
"legalName": "Advanced Global Health Limited",
"scheme": "GB-COH"
},
"name": "Advanced Global Health Limited",
"roles": [
"supplier"
]
},
{
"address": {
"countryName": "United Kingdom",
"locality": "Taunton",
"postalCode": "TA1 5DA",
"streetAddress": "Musgrove Park Hospital"
},
"id": "GB-FTS-1287",
"identifier": {
"legalName": "Somerset NHS Foundation Trust"
},
"name": "Somerset NHS Foundation Trust",
"roles": [
"reviewBody"
]
},
{
"address": {
"countryName": "United Kingdom",
"locality": "London",
"postalCode": "SE1 8UG",
"streetAddress": "Wellington House, 133-135 Waterloo Rd"
},
"id": "GB-FTS-130973",
"identifier": {
"legalName": "NHS England"
},
"name": "NHS England",
"roles": [
"mediationBody"
]
}
],
"tag": [
"award",
"contract"
],
"tender": {
"classification": {
"description": "Gynaecological hospital services",
"id": "85111300",
"scheme": "CPV"
},
"description": "Provision of a full end to end testing service, including sampling kit supply, sample transport, and result reporting.",
"id": "PATH018",
"items": [
{
"additionalClassifications": [
{
"description": "Pathology services",
"id": "85111800",
"scheme": "CPV"
}
],
"deliveryAddresses": [
{
"region": "UKK23"
}
],
"deliveryLocation": {
"description": "Somerset NHS foundation Trust Sites"
},
"id": "1",
"relatedLot": "1"
}
],
"legalBasis": {
"id": "32014L0024",
"scheme": "CELEX"
},
"lots": [
{
"awardCriteria": {
"criteria": [
{
"description": "100",
"name": "most suitable provider process",
"type": "cost"
}
]
},
"description": "Provision of a full end to end testing service, including sampling kit supply, sample transport, and result reporting.\nThe WID\u00ae-easy test is a new, minimally invasive test available in the UK that uses a simple vaginal swab to help detect or rule out the risk of endometrial (womb) cancer in women experiencing abnormal bleeding. It is a far less intrusive procedure, providing faster links to the appropriate clinical pathway. \n A service evaluation project would aim to test the initial adoption of the WID\u00ae-easy test at the Somerset NHS Foundation Trust. The WID\u00ae-easy test will be the frontline triage methodology for all women referred to the Trust 45 years or older with AUB and determine the next step in the clinical workflow. \nThis notice is an intention to award a contract under the most suitable provider process. \nThe approximate lifetime value of the contract is \u00a3435,000.00.\nThis is a new service with a new provider. \nThe dates between which the services are intended to be provided are between March 2026 and March 2027.",
"hasOptions": true,
"id": "1",
"options": {
"description": "1 x 12 month extension"
},
"status": "cancelled"
}
],
"mainProcurementCategory": "services",
"procurementMethod": "limited",
"procurementMethodDetails": "Award procedure without prior publication of a call for competition",
"procurementMethodRationale": "This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award. The standstill period begins on the day after the publication of this notice. Representations by providers must be made to decision makers by 25 February 2026. This contract has not yet formally been awarded; this notice serves as an intention to award under the PSR\u0027.",
"procurementMethodRationaleClassifications": [
{
"description": "The procurement falls outside the scope of application of the directive",
"id": "D_OUTSIDE_SCOPE",
"scheme": "TED_PT_AWARD_CONTRACT_WITHOUT_CALL"
}
],
"status": "complete",
"title": "WID-Easy Somerset Pilot"
}
}